Additionally, treatment of mice with TGR5-specific agonists has been shown to ameliorate many of these metabolic impairments, underscoring the potential therapeutic nature of TGR5 in treating metabolic disease [7,9,13,24,27,28,29,30]. Here, GPBAR1 is linked to Other metabolic disease.